Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03032445
Other study ID # Beer Trial
Secondary ID
Status Completed
Phase N/A
First received January 12, 2017
Last updated April 25, 2018
Start date March 1, 2017
Est. completion date May 21, 2017

Study information

Verified date April 2018
Source State University of New York - Upstate Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Athletes who are participating in the Keys100 Ultramarathon event in Key West, FL are eligible, based on inclusion criteria, to participate in this research study that is seeking to determine whether supplementation of beer (alcohol) immediately following a long distance ultramarathon race can positively impact exercise-associated hyponatremia [EAH].


Recruitment information / eligibility

Status Completed
Enrollment 43
Est. completion date May 21, 2017
Est. primary completion date May 21, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

- Completed informed consent

- Ability to read and speak English language

- Age 21 years or older

- Not considered a vulnerable population, such as pregnant (by history) or cognitively impaired.

- Able to tolerate needle exposure for blood draw

- Willing to drink alcoholic or nonalcoholic beer

- Willing not to eat or drink other than the study fluid during 1 hour study period

- Participating in 100 mile or 50 mile race

- To participate in the controlled part of the study the individual must have fully completed either the 100 mile or the 50 mile race.

Exclusion Criteria:

- Under age 21 years

- Vulnerable population, such as pregnant (by history) or cognitively impaired

- Subjects who are alcohol-naive (i.e first exposure to alcohol)

- Subjects with known familial and/or genetic backgrounds at higher risk for the development of alcohol dependence

- Subjects should not be seeking treatment for alcohol or drug abuse

- Subjects who are in general high risk for abuse such as those completing or participating in alcohol or drug abuse programs

- Subjects who have had a sustained period of abstinence, with history of heavy drinking problems, while living in the community

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Alcoholic Beer
Subject will be asked to consume alcoholic beer within 30 minutes. Subject will be monitored for 60 minutes at commencement of study beverage.
Non alcoholic beer
Subject will be asked to consume non alcoholic beer within 30 minutes. Subject will be monitored for 60 minutes at commencement of study beverage.

Locations

Country Name City State
United States SUNY Upstate Medical University Syracuse New York

Sponsors (1)

Lead Sponsor Collaborator
State University of New York - Upstate Medical University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in sodium level pre and post intervention One hour
Secondary Measurement of urine output One hour
Secondary Number of participants with abnormal laboratory values One hour
Secondary Level of cognition Cognitive level determined by assessment of clock drawing test. Within one month of intervention
See also
  Status Clinical Trial Phase
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Recruiting NCT04561531 - Efficacy and Safety of Bolus Comparing With Continuous Drip of 3% NaCl in Patients With Severe Symptomatic Hyponatremia. N/A
Terminated NCT02012959 - Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia Phase 3
Recruiting NCT02936167 - Comparison of Ringer Lactate and Isotonic Acetate Solution as Perioperative Maintenance Fluid for Children N/A
Completed NCT00621348 - Maintenance Intravenous Fluids in Children Phase 3
Terminated NCT03703713 - Colloid Osmotic Pressure and Osmolality in Hyponatremia
Completed NCT02926989 - Intravenous Fluids in Hospitalised Children Phase 4
Terminated NCT02959411 - Tolvaptan for Advanced or Refractory Heart Failure Phase 4
Completed NCT02573077 - An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy
Withdrawn NCT02667977 - Reexamining Hypotonic Intravenous Fluid Use N/A
Terminated NCT01708811 - Hyponatremia and Myometrium Contractility. An Invitro Study N/A
Completed NCT01456533 - Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients N/A
Withdrawn NCT01326429 - Frequency and Origin of Dysnatremias in the Emergency Department N/A
Terminated NCT01227512 - Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia Phase 3
Recruiting NCT06013800 - Hyponatremia Volume Status Analysis by Point-of-care Ultrasound
Terminated NCT04020926 - Impact of Hyponatremia on Muscle Strength, Gait and Cognitive Function
Withdrawn NCT02442674 - A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia Phase 3
Completed NCT02545101 - An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH N/A
Terminated NCT02215148 - Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients N/A
Recruiting NCT01748331 - The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia N/A